Lorus Therapeutics Inc. (TSX: LOR; AMEX: LRP), today announced the reduction of staff by approximately 35%. No figure was provided as how many employees will be laid off. As at May 31, 2005, Lorus had 72 full-time and 1 part-time employees. Lorus said the reduction in staff and other internal initiatives will provide a significant increase in cash for its operations through 2006 and beyond. During this period Lorus intends to focus on the creation of partnerships for drugs under clinical development, primarily, Virulizin(R) and GTI-2040.